Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response - Wikidata - wikimedia - TriplyDB

Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response

Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response

http://www.wikidata.org/entity/Q36240212

about

Understanding the pathogenesis of Kawasaki disease by network and pathway analysis Targeting the Fc receptor in autoimmune disease Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response.Human FcR polymorphism and disease.High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study Immunoglobulin Resistance in Kawasaki Disease.Imputation of class I and II HLA loci using high-density SNPs from ImmunoChip and their associations with Kawasaki disease in family-based study.Ethnic Kawasaki Disease Risk Associated with Blood Mercury and Cadmium in U.S. Children Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression.The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.Kawasaki disease and soy: potential role for isoflavone interaction with Fcγ receptors.Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?Recent Advances in Kawasaki Disease - Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014.Health impact of childhood and adolescent soy consumption.Absence of association of FCGR2A gene polymorphism rs1801274 with Kawasaki disease in Greek patients.Dissecting Kawasaki disease: a state-of-the-art review.Soy isoflavone intake is associated with risk of Kawasaki disease.DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease.The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.One Size Does Not Fit All: Genetic Prediction of Kawasaki Disease Treatment Response in Diverse Populations.Role of intravenous immunoglobulin in the treatment of Kawasaki disease.

P2860

Q26996702-37ABCCDB-0A82-4FC1-A266-A770ED5B501A Q27002843-25203538-E09A-4253-950F-6C4B045B7BE7 Q33686907-AFCD1BF6-C279-4168-952B-AE0D842A49F1 Q34351750-285DA408-F8B5-4254-8A02-B6CB59F34E6F Q34406254-747D2CEF-8AD4-43BE-80A9-1E51E3AA7309 Q34641944-6579B755-B1B3-4432-8D62-53C8EF8C69E2 Q35193974-7FCCB18D-4FD8-4CC9-B834-4200D36882FE Q35602584-3BDE04E9-A62F-49CC-A4B2-B1966D48862C Q36513183-A9DDFF91-386F-4A8D-9A22-4EFAC6DE7747 Q36655657-B7C7C877-3AA9-4EDE-BA4D-72C727610BAB Q37175810-9FFAAA57-827A-494E-8A17-16638BEEBA49 Q38061301-C0A7E556-1E55-487F-AC9C-4B4B578299F6 Q38344833-997231CD-4475-4BD7-A7FD-72192766D775 Q38575942-13F61D64-130E-4B32-B932-91C0EF81E939 Q38609844-D46EA612-3B48-48A0-9566-0F3A3F10E3C5 Q39202193-76D4952D-7D33-44CD-861A-4433CD99F8EA Q39401720-63AE83AA-B767-4D22-AB70-7B1D265AB328 Q40640712-734E8042-3E36-4EAA-B643-CD19C4C945EE Q42185658-65AF6FA0-3DE5-409F-A02A-6EF496595B4C Q42315522-D7DCEDAF-ACF6-420E-99D3-76DBC4958EA8 Q42678825-9AE636B1-2A26-4C4A-A0C7-7D8967B24AF7 Q47182586-593E5AA6-04E7-4AC5-9313-D337DF5CDE01 Q50071875-A859EEE0-E14B-423E-B528-1084DBC02ECB

P2860

Role of activating FcγR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response

http://www.wikidata.org/entity/Q36240212

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Role of activating FcγR gene p ...... venous immunoglobulin response

@ast

Role of activating FcγR gene p ...... venous immunoglobulin response

@en

type

label

Role of activating FcγR gene p ...... venous immunoglobulin response

@ast

Role of activating FcγR gene p ...... venous immunoglobulin response

@en

prefLabel

Role of activating FcγR gene p ...... venous immunoglobulin response

@ast

Role of activating FcγR gene p ...... venous immunoglobulin response

@en

P1433

Q36240212-595167D5-8FA2-47C1-9AEE-688D9C5BDDB6

P1476

Q36240212-C46BB2E9-8FC5-4EEC-8782-3281668D573A

P2093

Q36240212-06F768A5-F4FD-4B02-B2FD-A697E7CD2548

Q36240212-304F36FF-51BE-42E8-9E77-8D852E252B30

Q36240212-46E9C6AF-9D7C-4A91-8B4E-AD00BCAE988D

Q36240212-4D978BB4-6C7D-41DF-A7BB-D65D8810E782

Q36240212-5F53F8CA-41AF-4911-9FD9-34BF04DEF62F

Q36240212-6945C0CE-30E8-46C0-AAA5-40437A839AA3

Q36240212-884216FC-573F-452E-BAFA-547484CF8A2F

Q36240212-ABE9FC0C-DD8A-4941-BC0C-341B9DFC2FDE

Q36240212-AD3306DB-16C0-4CE0-975A-CE3FE1C315EE

Q36240212-F1FEE5F8-3FDF-4799-8475-64E34D4D4A5E

P2860

Q36240212-14763EBC-9CAC-4C49-8BCA-7E8DC23C366F

Q36240212-157C5062-63C6-4BC8-832F-E4C396F9908D

Q36240212-17E027A2-E555-495D-A24B-F08E44247B50

Q36240212-28A00606-EE64-4725-B25E-BF8C6DE3457A

Q36240212-2E051B8E-CB9F-4A44-8843-AB4A1D21516E

Q36240212-31745A77-53BC-4ED2-A788-4E20D9ED6223

Q36240212-3A38046E-F7B8-44F4-A02A-4F4A3CF07977

Q36240212-3DBC4207-A24A-4454-B359-59B8D1743E2C

Q36240212-4A8086CD-6DDE-46CF-A8DB-7A0E848CE73C

Q36240212-53503706-E6DF-43B0-8F5D-7515B854E1BB

P304

Q36240212-39C9A5C3-5493-458B-9E6E-34A7D8D6C85D

P31

Q36240212-160FE38E-63A3-4097-9AA5-33FF32BAB70A

P356

Q36240212-2977D927-94D2-4B5F-956F-997CB95E34F7

P433

Q36240212-5CD78BED-831F-4803-BB2B-FFB14ABB24AC

P478

Q36240212-5AB0BB2C-263B-4CE0-B276-83BEE2CFF85B

P577

Q36240212-0BF3CC44-F651-46A0-9C40-C37B1DC04FD3

P5875

Q36240212-CF2ED06A-8AC8-4F2E-867C-B3D373365906

P698

Q36240212-7075718D-4CDB-4CB5-A471-5BE42FE1EF30

P932

Q36240212-1832C0E6-BA85-4D2D-B5DD-F47AAB458621

P356

CIRCGENETICS.111.962464

P1433

Circulation: Cardiovascular Genetics

P1476

Role of activating FcγR gene p ...... venous immunoglobulin response

@en

P2093

Aaron Olson

http://www.w3.org/2001/XMLSchema#string

Aditi Shendre

http://www.w3.org/2001/XMLSchema#string

Hitendra Patel

http://www.w3.org/2001/XMLSchema#string

Howard Wiener

http://www.w3.org/2001/XMLSchema#string

Jeffrey C Edberg

http://www.w3.org/2001/XMLSchema#string

Jianming Wu

http://www.w3.org/2001/XMLSchema#string

Michael A Portman

http://www.w3.org/2001/XMLSchema#string

Neil E Bowles

http://www.w3.org/2001/XMLSchema#string

Richard A Kaslow

http://www.w3.org/2001/XMLSchema#string

Sadeep Shrestha

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Associ

The three genes of the human FCGR1 gene family encoding Fc gamma RI flank the centromere of chromosome 1 at 1p12 and 1q21

Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico

Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.

IgG Fc receptors

IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy.

IgG receptor polymorphisms: risk factors for disease.

[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]

A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa.

P304

309-316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCGENETICS.111.962464

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224917970

http://www.w3.org/2001/XMLSchema#string

P698

22565545

http://www.w3.org/2001/XMLSchema#string

P932

3444514

http://www.w3.org/2001/XMLSchema#string